Visceral adiposity index correlation with Rotterdam criteria in patients with polycystic ovary syndrome

نویسنده

  • Mohamed M. Aboelnaga
چکیده

Background: The present research explores the correlation of visceral obesity index with Rotterdam criteria (hyperandrogenism and/or hyperandrogenemia, oligomenorrhea and Ultrasound polycystic ovarian morphology) among Egyptian polycystic ovary syndrome patients. Methods: We enrolled one hundred female patients with polycystic ovary syndrome with age ranged 18-44 years (mean age 26.83±6.092 years). Results: VAI very strongly correlated with waist circumference, TG and HDL-c, also moderately correlated with systolic B.P, BMI, HOMA-IR and insulin levels, also we found only insulin, menstrual cycles per year number and FGS were significant predictors of hyperandrogenemia in PCOS patients. Only Ultrasound polycystic ovarian morphology was a significant risk factor for oligomenorrhea in PCOS patients in logistic regression analysis. VAI, TT and Farman gallawy score can significantly predict number of the menstrual cycles per year number (p <0.05). In logistic regression analysis, only oligomenorrhea was a significant independent risk factor for PCOM (p <0.05). In addition, only VAI was a significant independent (p <0.05) risk factor for metabolic syndrome. Conclusions: VAI was an independent significant predictor for metabolic syndrome in patients with PCOS and a good marker of cardiometabolic risk in PCOS patients. In addition, VAI was significant predictors of annual menusteral cycle but not testosterone levels or polycystic ovarian morphology in PCOS. This study confirms the value of VAI in identification of patient with risk for metabolic syndrome and cardiometabolic risk in PCOS patients, but not found a role for VAI in diagnosis of PCOS.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

شاخص چربی احشایی(VAI)، بهترین پیشگویی کننده مقاومت به انسولین و سندرم متابولیک در زنان مبتلا به سندرم تخمدان پلیکیستیک

Background: Considering the limited population-based studies and lack of a general consensus on the most sensitive and precise predictor of insulin resistance and metabolic syndrome in the women with polycystic ovary syndrome (PCOS), the present study was performed with the aim of comparing the validity of various available adiposity markers in these patients. Methods: In the national and popul...

متن کامل

P-182: The Comparison of Clinical and Laboratory Characteristics in Obese and Normal Weight Women with Polycystic Ovary Syndrome

Background: The main characteristic of polycystic ovary syndrome (PCOS) is oligomenorrhea with clinical and biochemical signs of hyperandrogenism(HA) and the phenotypic spectrum of PCOS is very broad. There are very limited studies about the features of patients with PCOS in Iran. The purpose of this study is to compare the clinical and laboratory characteristics of PCOS between the overweight ...

متن کامل

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome

Background: It is well known that there is a close relationship between elevated androgen plasma levels and the ultrasound findings of stromal hypertrophy in polycystic ovary syndrome (PCOS). The objective of this study was to investigate the effects metformin on the hyperandrogenism and ovarian volume in PCOS. Methods: The study is an unrandomized clinical trial with before–after desig...

متن کامل

Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran

Background The prevalence of metabolic syndrome (MetS) in polycystic ovary syndrome (PCOS) has been studied in different populations, but their results were so controversial regarding Iranian women. These controversial data indicated the need for more investigation of MetS characteristics in PCOS patients in our population. So this study aimed to evaluate the clinical and laboratory characteris...

متن کامل

P-220: A Two Purpose Use of Orlistat in Obese Women with Polycystic Ovary Syndrome: Weight Loss and Androgen Reduction

Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies in young women. PCOS affects 6% and 8% of women in reproductive age. Hyperandrogenism is the hallmark of PCOS. Clinically, it is possible to observe hirsutism, acne, androgenic alopecia, and signs of virilization. Laboratory examination reveals increased androgen levels. Excessive androgen has an important r...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2016